Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways

<p>Abstract</p> <p>IκBα is an inhibitor of the nuclear transcription factor NF-κB. Binding of IκBα to NF-κB inactivates the transcriptional activity of NF-κB. Expression of IκBα itself is regulated by NF-κB, which provides auto-regulation of this signaling pathway. Here we present...

Full description

Bibliographic Details
Main Authors: Sambucetti Lidia C, Zhu Lingyun, Ahsan Muhammad H, Zhang Ning, Purchio Anthony F, West David B
Format: Article
Language:English
Published: BMC 2005-10-01
Series:Journal of Inflammation
Subjects:
Online Access:http://www.journal-inflammation.com/content/2/1/10
_version_ 1818790602717790208
author Sambucetti Lidia C
Zhu Lingyun
Ahsan Muhammad H
Zhang Ning
Purchio Anthony F
West David B
author_facet Sambucetti Lidia C
Zhu Lingyun
Ahsan Muhammad H
Zhang Ning
Purchio Anthony F
West David B
author_sort Sambucetti Lidia C
collection DOAJ
description <p>Abstract</p> <p>IκBα is an inhibitor of the nuclear transcription factor NF-κB. Binding of IκBα to NF-κB inactivates the transcriptional activity of NF-κB. Expression of IκBα itself is regulated by NF-κB, which provides auto-regulation of this signaling pathway. Here we present a mouse model for monitoring <it>in vivo </it>IκBα expression by imaging <it>I</it>κ<it>B</it>α-<it>luc </it>transgenic mice for IκBα promoter driven luciferase activity. We demonstrated a rapid and systemic induction of IκBα expression in the transgenic mice following treatment with LPS. The induction was high in liver, spleen, lung and intestine and lower in the kidney, heart and brain. The luciferase induction in the liver correlated with increased IκBα mRNA level. Pre-treatment with proteasome inhibitor bortezomib dramatically suppressed LPS-induced luciferase activity. The p38 kinase inhibitor SB203580 also showed moderate inhibition of LPS-induced luciferase activity. Analysis of IκBα mRNA in the liver tissue showed a surprising increase of the IκBα mRNA after bortezomib and SB203580 treatments, which could be due to increased IκBα mRNA stability. Our data demonstrate that regulation of IκBα expression involves both the NF-κB and the p38 signaling pathways. The <it>I</it>κ<it>B</it>α-<it>luc </it>transgenic mice are useful for analyzing IκBα expression and the NF-κB transcriptional activity <it>in vivo</it>.</p>
first_indexed 2024-12-18T14:58:04Z
format Article
id doaj.art-4c54c7259ee64b97875ad65991d2c1f3
institution Directory Open Access Journal
issn 1476-9255
language English
last_indexed 2024-12-18T14:58:04Z
publishDate 2005-10-01
publisher BMC
record_format Article
series Journal of Inflammation
spelling doaj.art-4c54c7259ee64b97875ad65991d2c1f32022-12-21T21:03:59ZengBMCJournal of Inflammation1476-92552005-10-01211010.1186/1476-9255-2-10Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathwaysSambucetti Lidia CZhu LingyunAhsan Muhammad HZhang NingPurchio Anthony FWest David B<p>Abstract</p> <p>IκBα is an inhibitor of the nuclear transcription factor NF-κB. Binding of IκBα to NF-κB inactivates the transcriptional activity of NF-κB. Expression of IκBα itself is regulated by NF-κB, which provides auto-regulation of this signaling pathway. Here we present a mouse model for monitoring <it>in vivo </it>IκBα expression by imaging <it>I</it>κ<it>B</it>α-<it>luc </it>transgenic mice for IκBα promoter driven luciferase activity. We demonstrated a rapid and systemic induction of IκBα expression in the transgenic mice following treatment with LPS. The induction was high in liver, spleen, lung and intestine and lower in the kidney, heart and brain. The luciferase induction in the liver correlated with increased IκBα mRNA level. Pre-treatment with proteasome inhibitor bortezomib dramatically suppressed LPS-induced luciferase activity. The p38 kinase inhibitor SB203580 also showed moderate inhibition of LPS-induced luciferase activity. Analysis of IκBα mRNA in the liver tissue showed a surprising increase of the IκBα mRNA after bortezomib and SB203580 treatments, which could be due to increased IκBα mRNA stability. Our data demonstrate that regulation of IκBα expression involves both the NF-κB and the p38 signaling pathways. The <it>I</it>κ<it>B</it>α-<it>luc </it>transgenic mice are useful for analyzing IκBα expression and the NF-κB transcriptional activity <it>in vivo</it>.</p>http://www.journal-inflammation.com/content/2/1/10IkappaBNF-κBMAP kinasebortezomiblipopolysaccharidebioluminescent imaging
spellingShingle Sambucetti Lidia C
Zhu Lingyun
Ahsan Muhammad H
Zhang Ning
Purchio Anthony F
West David B
Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways
Journal of Inflammation
IkappaB
NF-κB
MAP kinase
bortezomib
lipopolysaccharide
bioluminescent imaging
title Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways
title_full Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways
title_fullStr Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways
title_full_unstemmed Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways
title_short Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways
title_sort regulation of iκbα expression involves both nf κb and the map kinase signaling pathways
topic IkappaB
NF-κB
MAP kinase
bortezomib
lipopolysaccharide
bioluminescent imaging
url http://www.journal-inflammation.com/content/2/1/10
work_keys_str_mv AT sambucettilidiac regulationofikbaexpressioninvolvesbothnfkbandthemapkinasesignalingpathways
AT zhulingyun regulationofikbaexpressioninvolvesbothnfkbandthemapkinasesignalingpathways
AT ahsanmuhammadh regulationofikbaexpressioninvolvesbothnfkbandthemapkinasesignalingpathways
AT zhangning regulationofikbaexpressioninvolvesbothnfkbandthemapkinasesignalingpathways
AT purchioanthonyf regulationofikbaexpressioninvolvesbothnfkbandthemapkinasesignalingpathways
AT westdavidb regulationofikbaexpressioninvolvesbothnfkbandthemapkinasesignalingpathways